Primecap Management
BMRN icon

Primecap Management’s BioMarin Pharmaceuticals BMRN Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$867M Sell
15,772,173
-2,001,108
-11% -$110M 0.69% 44
2025
Q1
$1.26B Sell
17,773,281
-415,890
-2% -$29.4M 1.04% 29
2024
Q4
$1.2B Sell
18,189,171
-678,264
-4% -$44.6M 0.93% 35
2024
Q3
$1.33B Buy
18,867,435
+77,350
+0.4% +$5.44M 0.98% 30
2024
Q2
$1.55B Buy
18,790,085
+76,190
+0.4% +$6.27M 1.12% 23
2024
Q1
$1.63B Buy
18,713,895
+299,521
+2% +$26.2M 1.22% 19
2023
Q4
$1.78B Buy
18,414,374
+7,835
+0% +$755K 1.41% 18
2023
Q3
$1.63B Buy
18,406,539
+22,920
+0.1% +$2.03M 1.37% 18
2023
Q2
$1.59B Buy
18,383,619
+140,190
+0.8% +$12.2M 1.33% 19
2023
Q1
$1.77B Buy
18,243,429
+662,570
+4% +$64.4M 1.55% 17
2022
Q4
$1.82B Sell
17,580,859
-44,646
-0.3% -$4.62M 1.67% 15
2022
Q3
$1.49B Sell
17,625,505
-52,980
-0.3% -$4.49M 1.45% 18
2022
Q2
$1.47B Sell
17,678,485
-100,985
-0.6% -$8.37M 1.31% 22
2022
Q1
$1.37B Sell
17,779,470
-25,310
-0.1% -$1.95M 1.03% 27
2021
Q4
$1.57B Sell
17,804,780
-132,550
-0.7% -$11.7M 1.09% 26
2021
Q3
$1.39B Sell
17,937,330
-15,736
-0.1% -$1.22M 0.98% 27
2021
Q2
$1.5B Sell
17,953,066
-204,728
-1% -$17.1M 1.01% 27
2021
Q1
$1.37B Buy
18,157,794
+9,833
+0.1% +$742K 0.96% 31
2020
Q4
$1.59B Sell
18,147,961
-43,580
-0.2% -$3.82M 1.18% 24
2020
Q3
$1.38B Buy
18,191,541
+307,570
+2% +$23.4M 1.14% 22
2020
Q2
$2.21B Buy
17,883,971
+74,204
+0.4% +$9.15M 1.89% 13
2020
Q1
$1.5B Buy
17,809,767
+1,480,447
+9% +$125M 1.48% 18
2019
Q4
$1.38B Buy
16,329,320
+1,167,246
+8% +$98.7M 1% 29
2019
Q3
$1.02B Buy
15,162,074
+878,321
+6% +$59.2M 0.82% 38
2019
Q2
$1.22B Buy
14,283,753
+92,880
+0.7% +$7.96M 0.9% 34
2019
Q1
$1.26B Buy
14,190,873
+5,700
+0% +$506K 0.93% 33
2018
Q4
$1.21B Sell
14,185,173
-23,312
-0.2% -$1.99M 0.98% 30
2018
Q3
$1.38B Sell
14,208,485
-32,304
-0.2% -$3.13M 0.93% 33
2018
Q2
$1.34B Buy
14,240,789
+474,250
+3% +$44.7M 0.99% 30
2018
Q1
$1.12B Buy
13,766,539
+3,521,244
+34% +$285M 0.84% 37
2017
Q4
$914M Buy
10,245,295
+606,651
+6% +$54.1M 0.7% 42
2017
Q3
$897M Buy
9,638,644
+328,420
+4% +$30.6M 0.74% 38
2017
Q2
$846M Buy
9,310,224
+597,956
+7% +$54.3M 0.73% 42
2017
Q1
$765M Buy
8,712,268
+826,320
+10% +$72.5M 0.69% 45
2016
Q4
$653M Buy
7,885,948
+777,819
+11% +$64.4M 0.64% 46
2016
Q3
$658M Sell
7,108,129
-211,190
-3% -$19.5M 0.66% 46
2016
Q2
$569M Sell
7,319,319
-31,050
-0.4% -$2.42M 0.61% 48
2016
Q1
$606M Buy
7,350,369
+19,680
+0.3% +$1.62M 0.63% 50
2015
Q4
$768M Sell
7,330,689
-34,350
-0.5% -$3.6M 0.79% 39
2015
Q3
$776M Sell
7,365,039
-627,710
-8% -$66.1M 0.86% 31
2015
Q2
$1.09B Sell
7,992,749
-32,259
-0.4% -$4.41M 1.08% 23
2015
Q1
$1B Buy
8,025,008
+8,490
+0.1% +$1.06M 0.98% 27
2014
Q4
$725M Sell
8,016,518
-27,400
-0.3% -$2.48M 0.73% 39
2014
Q3
$580M Sell
8,043,918
-20,301
-0.3% -$1.46M 0.62% 44
2014
Q2
$502M Sell
8,064,219
-99,500
-1% -$6.19M 0.55% 50
2014
Q1
$557M Buy
8,163,719
+603,590
+8% +$41.2M 0.63% 44
2013
Q4
$532M Sell
7,560,129
-46,800
-0.6% -$3.29M 0.64% 38
2013
Q3
$549M Sell
7,606,929
-77,400
-1% -$5.59M 0.72% 36
2013
Q2
$429M Buy
+7,684,329
New +$429M 0.61% 46